Immunex Enbrel sales team
Executive Summary
Barry Labinger named senior VP and general manager, overseeing Enbrel and specialty therapeutics sales and marketing. Labinger assumes duties previously held by Mark Booth, who is moving to Takeda North America to the newly created position of exec VP. Labinger was previously VP of marketing for Enbrel. Immunex also names Scott Burton as Enbrel VP-sales to head the company's first internal sales force for the rheumatoid arthritis drug. Burton comes to Immunex from Bristol-Myers Squibb